KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363,571 | +8.3% | 37,754 | +1.2% | 0.05% | 0.0% |
| Q2 2023 | $335,754 | +14.4% | 37,306 | -0.1% | 0.05% | +15.0% |
| Q1 2023 | $293,500 | -7.7% | 37,341 | -20.6% | 0.04% | -21.6% |
| Q4 2022 | $318,017 | +128.8% | 47,044 | +233.3% | 0.05% | +325.0% |
| Q2 2022 | $139,000 | -29.8% | 14,113 | -13.5% | 0.01% | -7.7% |
| Q2 2020 | $198,000 | +33.8% | 16,325 | -15.4% | 0.01% | +8.3% |
| Q1 2020 | $148,000 | -65.3% | 19,300 | -19.4% | 0.01% | -53.8% |
| Q4 2019 | $427,000 | – | 23,952 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |